Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,422 | -83,815 | -64,993 | -46,759 | -24,436 |
| Depreciation Amortization | 548 | 1,637 | 1,299 | 949 | 512 |
| Accounts receivable | 45 | 440 | 146 | 336 | -197 |
| Accounts payable and accrued liabilities | 1,384 | -2,641 | 859 | -1,352 | -338 |
| Other Working Capital | -1,364 | -5,503 | -4,345 | -5,476 | -4,409 |
| Other Operating Activity | 175 | 9,738 | 5,030 | 5,366 | 2,605 |
| Operating Cash Flow | $-17,634 | $-80,144 | $-62,004 | $-46,936 | $-26,263 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,750 | 57,046 | 43,046 | 26,546 | 25,796 |
| PPE Investments | N/A | -38 | -38 | -37 | -37 |
| Investing Cash Flow | $17,750 | $57,008 | $43,008 | $26,509 | $25,759 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | -418 | -410 | -347 | -172 |
| Common Stock Issued | 18 | 43,096 | 43,096 | 43,163 | 184 |
| Financing Cash Flow | $10 | $42,678 | $42,686 | $42,816 | $12 |
| Exchange Rate Effect | 11 | -106 | -152 | -95 | -23 |
| Beginning Cash Position | 36,416 | 16,980 | 16,980 | 16,980 | 16,980 |
| End Cash Position | 36,553 | 36,416 | 40,518 | 39,274 | 16,465 |
| Net Cash Flow | $137 | $19,436 | $23,538 | $22,294 | $-515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,634 | -80,144 | -62,004 | -46,936 | -26,263 |
| Capital Expenditure | N/A | -38 | -38 | -37 | -37 |
| Free Cash Flow | -17,634 | -80,182 | -62,042 | -46,973 | -26,300 |